Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07404657Not Yet Recruiting

Preliminary Assessment of an Automated Tool for Diabetic Retinopathy Screening

Role: lead

NCT05801471Recruiting

Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression

Role: lead

NCT06991127Not ApplicableRecruiting

Clinical Investigation of MAIA Microperimeter Device: Mesopic Normative Database Collection

Role: lead

NCT06071546Not ApplicableCompleted

Clinical Investigation of a New Version of MAIA Microperimeter on Healthy Subjects and Patients With Retinal Pathology

Role: lead

All 4 trials loaded